Evidence map›Paper›PMID 29117863›Full record

ArticleBMC biology2017

RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.

Nila Roy Choudhury, Gregory Heikel, Maryia Trubitsyna, Peter Kubik, Jakub Stanislaw Nowak, Shaun Webb, Sander Granneman, Christos Spanos, Juri Rappsilber, Alfredo Castello and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 200 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Global Co-regulatory Cross Talk Between mMolecular neurobiology · 2025
    Article
  15. The regulation of innate antiviral immunity by TRIM56.Infectious diseases & immunity · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Nila Roy ChoudhuryWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh, EH9 3BF, UK.
Gregory HeikelWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh, EH9 3BF, UK.
Maryia TrubitsynaInstitute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Roger Land Building, Edinburgh, EH9 3FF, UK.
Peter KubikWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh, EH9 3BF, UK.
Jakub Stanislaw NowakWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh, EH9 3BF, UK.
Shaun WebbWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh, EH9 3BF, UK.
Sander GrannemanCentre for Synthetic and Systems Biology (SynthSys), University of Edinburgh, CH Waddington Building, Edinburgh, EH9 3BF, UK.
Christos SpanosWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh, EH9 3BF, UK.
Juri RappsilberWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh, EH9 3BF, UK.
Alfredo CastelloDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
Gracjan MichlewskiWellcome Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Edinburgh, EH9 3BF, UK. gracjan.michlewski@ed.ac.uk.ORCID 0000-0002-7409-9619
Wellcome Centre for Cell Biology · GBUniversity of Edinburgh · GBUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J004243/1Medical Research Council G1000564Medical Research Council MR/K001744/1Medical Research Council MR/L019434/1Wellcome Trust 077707Wellcome Trust 084229Wellcome Trust 091020Wellcome Trust 091549Wellcome Trust 092076Wellcome Trust 096996Wellcome Trust 103139/Z/13/ZWellcome Trust 105246
6 · The paper itself

Abstract

backgroundTRIM25 is a novel RNA-binding protein and a member of the Tripartite Motif (TRIM) family of E3 ubiquitin ligases, which plays a pivotal role in the innate immune response. However, there is scarce knowledge about its RNA-related roles in cell biology. Furthermore, its RNA-binding domain has not been characterized.

resultsHere, we reveal that the RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain, which we postulate to be a novel RNA-binding domain. Using CLIP-seq and SILAC-based co-immunoprecipitation assays, we uncover TRIM25's endogenous RNA targets and protein binding partners. We demonstrate that TRIM25 controls the levels of Zinc Finger Antiviral Protein (ZAP). Finally, we show that the RNA-binding activity of TRIM25 is important for its ubiquitin ligase activity towards itself (autoubiquitination) and its physiologically relevant target ZAP.

conclusionsOur results suggest that many other proteins with the PRY/SPRY domain could have yet uncharacterized RNA-binding potential. Together, our data reveal new insights into the molecular roles and characteristics of RNA-binding E3 ubiquitin ligases and demonstrate that RNA could be an essential factor in their enzymatic activity.

Indexed as

B30.2-SPRY DomainUbiquitinationProtein BindingRecombinant ProteinsRNATranscription FactorsTripartite Motif ProteinsUbiquitin-Protein LigasesRecombinant ProteinsRNATranscription FactorsTRIM25 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesNovel RNA-binding proteinsPRY/SPRYRNA-binding domainTRIM25ZAP

Identifiers

PMID29117863
PMCPMC5678581
OpenAlexW2762091655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.